$MMED (MINIMED GROUP) — 8-K: Q1 FY27 EPS $0.00; revenue $843M +16.6% Y/Y; FY27 organic growth guide raised to 10.5%

MiniMed printed Q1 FY27 GAAP EPS of $0.00, with no consensus available. Revenue of $843M rose 16.6% as reported and 15.8% organic, including a 4-6% extra-week benefit. FY27 organic revenue growth guidance was raised to ~10.5% from ~10%, with adjusted EBITDA margin reaffirmed at ~16%. U.S. growth accelerated to 13.1%, driven by the MiniMed Flex launch and new sensor rollouts.

MiniMed printed Q1 FY27 GAAP EPS of $0.00, with no consensus available. Revenue of $843M rose 16.6% as reported and 15.8% organic, including a 4-6% extra-week benefit. FY27 organic revenue growth guidance was raised to ~10.5% from ~10%, with adjusted EBITDA margin reaffirmed at ~16%. U.S. growth accelerated to 13.1%, driven by the MiniMed Flex launch and new sensor rollouts.